Lifestance Health
LFST
109 hedge funds and large institutions have $2.66B invested in Lifestance Health in 2023 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 52 increasing their positions, 17 reducing their positions, and 8 closing their positions.
250% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 8
206% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 17
24% more capital invested
Capital invested by funds: $2.14B → $2.66B (+$520M)
22% more funds holding
Funds holding: 89 → 109 (+20)
0.83% more ownership
Funds ownership: 76.41% → 77.23% (+0.83%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
46% less call options, than puts
Call options by funds: $860K | Put options by funds: $1.59M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$15.6M |
| 2 |
DCP
Durable Capital Partners
Bethesda,
Maryland
|
+$7.84M |
| 3 |
Jennison Associates
New York
|
+$6.96M |
| 4 |
State Street
Boston,
Massachusetts
|
+$5.43M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SP
Stockbridge Partners
Boston,
Massachusetts
|
-$25.3M |
| 2 |
Millennium Management
New York
|
-$7.02M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$6.37M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$2.19M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1.19M |
LFST Hedge Fund Activity: Q2 2023 in Review
109 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Lifestance Health (LFST) for Q2 2023, worth a combined $2.66B — up 24% from $2.14B a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new LFST positions and 8 closed out — a net gain of 20 holders — while 52 added to existing stakes and 17 trimmed.
The largest buyer was BlackRock, adding an estimated $15.6M. The largest seller was Stockbridge Partners, cutting an estimated $25.3M.
- 109 institutional investors held Lifestance Health (LFST) as of Q2 2023, up from 89 in Q1 2023.
- Funds reported $2.66B of Lifestance Health stock for Q2 2023, up 24% quarter-over-quarter.
- 28 funds opened new Lifestance Health positions in Q2 2023 and 8 closed out, a net change of +20 holders.
- The largest Lifestance Health buyer in Q2 2023 was BlackRock, an estimated $15.6M added.
- The largest Lifestance Health seller in Q2 2023 was Stockbridge Partners, an estimated $25.3M sold.
Based on aggregated 13F filings for Q2 2023.